Keyphrases
Atrial Fibrillation
100%
Confidence Interval
92%
Heart Failure
81%
National Cohort Study
77%
Hazard Ratio
68%
Myocardial Infarction
56%
Denmark
54%
Out-of-hospital Cardiac Arrest
54%
All-cause Mortality
52%
Cardiovascular Mortality
40%
Patients with Heart Failure
35%
Acute Myocardial Infarction
35%
Cardiovascular Risk
33%
Cardiovascular Disease
30%
ST-elevation Myocardial Infarction (STEMI)
29%
Type 2 Diabetic Patients
27%
Infective Endocarditis
27%
Heart Failure with Preserved Ejection Fraction (HFpEF)
26%
Type 2 Diabetes Mellitus (T2DM)
25%
Comorbidity
24%
Diabetes
23%
COVID-19
23%
Left Ventricular Ejection Fraction
23%
Incidence Rate
23%
Hypertension
22%
Risk Factors
22%
Odds Ratio
22%
Echocardiography
22%
Implantable Defibrillator
21%
Psoriasis
21%
Nationwide Registry
21%
High Risk
20%
Cardiovascular Events
20%
Percutaneous Coronary Intervention
20%
Left Ventricular Function
20%
Ischemic Heart Disease
19%
Prognostic Value
19%
Heart Failure Patients
19%
Placebo
19%
Acute Coronary Syndrome
19%
Hospitalization
19%
Type 1 Diabetes Mellitus (T1DM)
18%
AIMS™
18%
Clinical Outcomes
18%
Copenhagen
18%
Cardiac Resynchronization Therapy
18%
Global Longitudinal Strain
17%
Coronary Artery Disease
17%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
16%
Major Adverse Cardiovascular Events
16%
Randomized Clinical Trial
16%
Chronic Obstructive Pulmonary Disease
16%
Echocardiographic
15%
Cardiac Function
15%
Randomized Controlled Trial
15%
Sudden Cardiac Death
15%
Beta-blockers
15%
Multivariable
14%
Primary Percutaneous Coronary Intervention
14%
Ventricular Arrhythmia
14%
Heart Failure Hospitalization
14%
Meta-analysis
13%
Reduced Ejection Fraction
12%
Ischemic Stroke
12%
Temporal Trends
12%
Mortality Risk
12%
Copenhagen City Heart Study
12%
Low Risk
12%
Body Mass Index
11%
Risk of Death
11%
Patients with Diabetes
11%
Chronic Kidney Disease
11%
Heart Rate
11%
Cardioverter-defibrillator Implantation
11%
Adverse Outcomes
11%
Cardiovascular Outcomes
11%
Cardiac Arrest
10%
Coronary Angiography
10%
Vitamin K Antagonists
10%
Risk Stratification
10%
Bleeding
10%
Randomized Trial
10%
Nationwide Registers
10%
Aortic Stenosis
9%
Tissue Doppler Imaging
9%
Stroke Risk
9%
Systematic Meta-analysis
9%
Automated External Defibrillator
9%
Arrhythmia
9%
Dapagliflozin
9%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
9%
Syncope
9%
Long-run Risk
9%
Angina Pectoris
9%
Myocardial Infarction Patients
9%
Clopidogrel
9%
Without Diabetes
9%
Endocarditis
9%
Left Ventricular Hypertrophy
9%
Adjusted Hazard Ratio
9%
Medicine and Dentistry
Heart Failure
97%
Atrial Fibrillation
77%
Cohort Analysis
68%
Cardiovascular System
67%
Hazard Ratio
48%
Cardiovascular Disease
43%
Out of Hospital Cardiac Arrest
38%
Apoplexy
34%
Myocardial Infarction
31%
Echocardiography
29%
Diabetes
29%
All Cause Mortality
25%
Implantable Automatic Defibrillator
23%
Coronary Artery Disease
22%
Population
22%
Maturity Onset Diabetes of the Young
22%
Ejection Fraction
21%
Disease
21%
Prevalence
20%
Cardiovascular Risk
20%
Patient with Type 2 Diabetes
20%
Symptom
19%
Ischemic Heart Disease
19%
Heart Left Ventricle Ejection Fraction
19%
COVID-19
18%
Infective Endocarditis
18%
Resuscitation
18%
Acute Coronary Syndrome
17%
Acute Heart Infarction
16%
Placebo
16%
Defibrillator
16%
Diabetes Mellitus
15%
Cardiac Resynchronization Therapy
15%
Electrocardiogram
15%
ST Segment Elevation Myocardial Infarction
15%
Percutaneous Coronary Intervention
14%
Proportional Hazards Model
14%
Diagnosis
14%
Coronary Angiography
13%
Randomized Controlled Trial
13%
Antithrombotic
13%
Sudden Cardiac Death
13%
Randomized Clinical Trial
13%
Tissue Doppler Imaging
13%
Triage
13%
Odds Ratio
12%
Heart Arrest
12%
Systolic Function
12%
Drug Therapy
11%
Heart Function
11%
Infection
11%
Brain Ischemia
11%
Heart Failure with Reduced Ejection Fraction
10%
Malignant Neoplasm
10%
Chronic Kidney Disease
10%
Heart Disease
10%
Psoriasis
10%
Meta-Analysis
10%
Aortic Stenosis
10%
Systematic Review
10%
Biological Marker
10%
Diastolic Function
9%
Chronic Obstructive Pulmonary Disease
9%
Catheter Ablation
9%
Brain Natriuretic Peptide
9%
Body Mass Index
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Amino Terminal Sequence
9%
Risk Stratification
8%
Primary Percutaneous Coronary Intervention
8%
Hemodynamic
8%
Blood Pressure
8%
Outpatient
8%
Faintness
8%
Thromboembolism
7%
Heart Failure with Preserved Ejection Fraction
7%
Quality of Life
7%
Cardiac Magnetic Resonance Imaging
7%
Adverse Event
7%
Systolic Heart Failure
7%
Cardiovascular Mortality
7%
Left Ventricular Hypertrophy
7%
Speckle Tracking Echocardiography
7%
Glomerular Filtration Rate
7%
Vitamin K Antagonist
7%
Empagliflozin
7%
Cardiac Dysrhythmia
6%
Bleeding
6%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Adverse Outcome
6%
Diastolic Dysfunction
6%
Computer Assisted Tomography
6%
Atherosclerosis
6%
Neonatal Infant
6%
Defibrillation
6%
Cross Sectional Study
6%
Population Research
6%
Coronary Artery
6%
Patient-Reported Outcome
6%
Endocarditis
6%